ArticleInternal and emergency medicine2023

Crucial safety issues on Janus kinase inhibitors in rheumatoid arthritis might be associated with the lack of LDL-cholesterol management: a reasoned literature analysis.

Salvatore CorraoPubMed ↗Publisher ↗

No numbers read from the abstract.